|
|
negative regulation of t cell cytokine production
|
GO:0002725 |
1 |
0.326
|
Human |
|
|
negative regulation of interleukin 13 secretion
|
GO:2000666 |
1 |
0.310
|
Human |
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.205
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.199
|
Human |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.197
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.192
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.191
|
Human |
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.191
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.179
|
Human |
|
|
negative regulation of interleukin 5 secretion
|
GO:2000663 |
1 |
0.165
|
Human |
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.157
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.144
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.142
|
Human |
|
|
circulatory system process
|
GO:0003013 |
197 |
0.130
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.126
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.123
|
Human |
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.119
|
Human |
|
|
epidermis development
|
GO:0008544 |
187 |
0.118
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.117
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.116
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.115
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.115
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.113
|
Human |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.109
|
|
|
|
entry into host
|
GO:0044409 |
15 |
0.107
|
Human |
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.102
|
Human |
|
|
cytokine production
|
GO:0001816 |
319 |
0.098
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.097
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.094
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.092
|
Human |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.091
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.084
|
Human |
|
|
viral process
|
GO:0016032 |
41 |
0.084
|
Human |
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.082
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.082
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.082
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.081
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.078
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.076
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.073
|
Mouse |
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.073
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.071
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.070
|
Human |
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.068
|
Human |
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.068
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.067
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.066
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.066
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.065
|
Human |
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.065
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.065
|
Human |
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.065
|
Human |
|
|
immune effector process
|
GO:0002252 |
321 |
0.065
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.062
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.062
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.061
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.060
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.059
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.057
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.057
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.057
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.055
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.054
|
|
|
|
negative regulation of viral entry into host cell
|
GO:0046597 |
10 |
0.054
|
Human |
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.053
|
Human |
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.053
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.053
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.052
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.051
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.050
|
Human |
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.049
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.047
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.047
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.045
|
Human |
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.045
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.044
|
|
|
|
negative regulation of interleukin 13 production
|
GO:0032696 |
2 |
0.044
|
Human |
|
|
detection of chemical stimulus involved in sensory perception of smell
|
GO:0050911 |
4 |
0.044
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.044
|
Human |
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.044
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.044
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.042
|
Mouse |
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.042
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.042
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.042
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.041
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.041
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.041
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.039
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.039
|
|
|
|
regulation of t helper 2 cell cytokine production
|
GO:2000551 |
3 |
0.038
|
Human |
|
|
natural killer cell activation involved in immune response
|
GO:0002323 |
10 |
0.038
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.038
|
Human |
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.037
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.037
|
Human |
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.036
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.036
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.035
|
|
|
|
superior vena cava morphogenesis
|
GO:0060578 |
1 |
0.035
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.035
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.034
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.034
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.034
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.034
|
Human |
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.034
|
Human |
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.034
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.034
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.033
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.033
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.033
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.033
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
23 |
0.033
|
Human |
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.033
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.033
|
Human |
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.032
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.032
|
Human |
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.032
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.032
|
Mouse |
|
|
gland development
|
GO:0048732 |
330 |
0.032
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.032
|
Human |
|
|
gliogenesis
|
GO:0042063 |
141 |
0.031
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.031
|
Human |
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.031
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.031
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.030
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.030
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.030
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.030
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.029
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.029
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.029
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.029
|
Human |
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
15 |
0.029
|
Human |
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.029
|
Mouse |
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.029
|
|
|
|
learning
|
GO:0007612 |
98 |
0.028
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.028
|
Human |
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.028
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.028
|
Human Mouse |
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.028
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.027
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.027
|
Human |
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.027
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.027
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.026
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.026
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.026
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.026
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.026
|
Human |
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.026
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.026
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.026
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.025
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.025
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.025
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.025
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.025
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.025
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.025
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.025
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.025
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.024
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.024
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.024
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.024
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.024
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.024
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.024
|
|
|
|
tyrosine phosphorylation of stat protein
|
GO:0007260 |
23 |
0.024
|
Human |
|
|
cognition
|
GO:0050890 |
149 |
0.024
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.023
|
|
|
|
regulation of t cell mediated immunity
|
GO:0002709 |
34 |
0.023
|
Human |
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.023
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.023
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.023
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.023
|
Human |
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.023
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.023
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.023
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.023
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.022
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.022
|
Human |
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.022
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.022
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.022
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.022
|
Mouse |
|
|
viral life cycle
|
GO:0019058 |
36 |
0.022
|
Human |
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.021
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.021
|
Human |
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.021
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
15 |
0.021
|
Human |
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.021
|
Human |
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.021
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.021
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.021
|
Human |
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.021
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.021
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.020
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.020
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.020
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.020
|
Human |
|
|
inflammatory response
|
GO:0006954 |
244 |
0.020
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.020
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.020
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.019
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.019
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.019
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.019
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.019
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.019
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.019
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.019
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.019
|
|
|
|
regulation of canonical wnt signaling pathway involved in cardiac muscle cell fate commitment
|
GO:1901295 |
1 |
0.019
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.019
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.019
|
|
|
|
adenylate cyclase inhibiting serotonin receptor signaling pathway
|
GO:0007198 |
1 |
0.019
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.019
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.019
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.018
|
Human |
|
|
single fertilization
|
GO:0007338 |
82 |
0.018
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.018
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.018
|
Human |
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.018
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.018
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.018
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.018
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.018
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.018
|
Human |
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.018
|
Human |
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.018
|
Human |
|
|
digestion
|
GO:0007586 |
40 |
0.018
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.018
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.018
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.018
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.017
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.017
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.017
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.017
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.017
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.017
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.017
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.017
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.017
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.017
|
Mouse |
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.017
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.017
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.017
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.016
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.016
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.016
|
Human |
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.016
|
|
|
|
type 2 immune response
|
GO:0042092 |
23 |
0.016
|
Human |
|
|
regulation of tyrosine phosphorylation of stat protein
|
GO:0042509 |
20 |
0.016
|
Human |
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.016
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.016
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.016
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.016
|
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
22 |
0.016
|
Human |
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.016
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.016
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.016
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.016
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.016
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.016
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.016
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.016
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.016
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.015
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.015
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.015
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.015
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.015
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.015
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.015
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.015
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.015
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.015
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.015
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.015
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.015
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.015
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.015
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.015
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.015
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.015
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.015
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.015
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.015
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.015
|
Human |
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.015
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.015
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.014
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.014
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.014
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.014
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.014
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.014
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.014
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.014
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.014
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.014
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.014
|
Human |
|
|
insulin secretion
|
GO:0030073 |
89 |
0.014
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.014
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.014
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.014
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.014
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.014
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.014
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.014
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.014
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.014
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.014
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.014
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.014
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.014
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.014
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.014
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.014
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.014
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.014
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.014
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.014
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.014
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.014
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.014
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.013
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.013
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.013
|
Human |
|
|
protein maturation
|
GO:0051604 |
176 |
0.013
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.013
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.013
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.013
|
|
|
|
subthalamic nucleus development
|
GO:0021763 |
1 |
0.013
|
|
|
|
negative regulation of adaptive immune response
|
GO:0002820 |
25 |
0.013
|
Human |
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.013
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.013
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.013
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.013
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.013
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.013
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.013
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.013
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.013
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.013
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.013
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.013
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.013
|
Human |
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.012
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.012
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.012
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.012
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.012
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.012
|
|
|
|
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002823 |
23 |
0.012
|
Human |
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.012
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.012
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.012
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.012
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.012
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in ventral spinal cord interneuron specification
|
GO:0021913 |
4 |
0.012
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.012
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.012
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.012
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.012
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.012
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.012
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.012
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.011
|
Human |
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.011
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.011
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.011
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.011
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.011
|
Human Mouse |
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.011
|
Human Mouse |
|
|
thymus development
|
GO:0048538 |
41 |
0.011
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.011
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.011
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.011
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.011
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.011
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.011
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.011
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.011
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.011
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.011
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.011
|
Human |
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.011
|
|
|
|
negative regulation of protein secretion
|
GO:0050709 |
20 |
0.011
|
Human |
|
|
adult behavior
|
GO:0030534 |
135 |
0.011
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.011
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.011
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.011
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.011
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.011
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.011
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.011
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.011
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.011
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.011
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.011
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.011
|
|
|
|
negative regulation of lymphocyte mediated immunity
|
GO:0002707 |
21 |
0.011
|
Human |
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.011
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.011
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.011
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.011
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.011
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.011
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.011
|
|
|
|
tyrosine phosphorylation of stat3 protein
|
GO:0042503 |
12 |
0.011
|
Human |
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.011
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.010
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.010
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.010
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.010
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.010
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.010
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.010
|
|
|
|
regulation of isoprenoid metabolic process
|
GO:0019747 |
1 |
0.010
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.010
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.010
|
Human |
|
|
movement in host environment
|
GO:0052126 |
15 |
0.010
|
Human |
|
|
somite development
|
GO:0061053 |
81 |
0.010
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.010
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.010
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.010
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.010
|
Human |
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.010
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.010
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.010
|
|
